224 related articles for article (PubMed ID: 36357014)
1. Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices.
Price MJ; Friedman DJ; Du C; Wang Y; Lin Z; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 Nov; 15(21):2115-2123. PubMed ID: 36357014
[TBL] [Abstract][Full Text] [Related]
2. Two-Year Outcomes With a Next-Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial.
Doshi SK; Kar S; Sadhu A; Horton R; Osorio J; Ellis C; Stone J; Shah M; Dukkipati SR; Adler S; Nair DG; Kim J; Wazni O; Price MJ; Holmes DR; Shipley R; Christen T; Allocco DJ; Reddy VY;
J Am Heart Assoc; 2023 Feb; 12(4):e026295. PubMed ID: 36789852
[TBL] [Abstract][Full Text] [Related]
3. Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry.
Berti S; De Caterina AR; Grasso C; Casu G; Giacchi G; Pagnotta P; Maremmani M; Mazzone P; Limite L; Tomassini F; Greco F; Romeo MR; Caramanno G; Fassini G; Geraci S; Chiarito M; Tondo C; Tamburino C; Contarini M
Front Cardiovasc Med; 2023; 10():1115811. PubMed ID: 37180775
[TBL] [Abstract][Full Text] [Related]
4. The ALSTER-FLX Registry: 3-Month outcomes after left atrial appendage occlusion using a next-generation device, a matched-pair analysis to EWOLUTION.
Paitazoglou C; Meincke F; Bergmann MW; Eitel I; Fink T; Vireca E; Wohlmuth P; Veliqi E; Willems S; Markiewicz A; Grygier M
Heart Rhythm; 2022 Jun; 19(6):917-926. PubMed ID: 35181483
[TBL] [Abstract][Full Text] [Related]
5. Comparative Data of Procedural and Midterm Outcomes in Patients Who Underwent Percutaneous Left Atrial Appendage Closure Between the WATCHMAN FLX and WATCHMAN 2.5 Devices - Insight From the OCEAN-LAAC Registry.
Nakashima M; Yamamoto M; Sago M; Tanaka S; Chatani R; Asami M; Hachinohe D; Naganuma T; Ohno Y; Tani T; Okamatsu H; Mizutani K; Watanabe Y; Izumo M; Saji M; Mizuno S; Ueno H; Kubo S; Shirai S; Hayashida K;
Circ J; 2024 Jun; 88(7):1187-1197. PubMed ID: 38763735
[TBL] [Abstract][Full Text] [Related]
6. Utilization and procedural adverse outcomes associated with Watchman device implantation.
Khalil F; Arora S; Killu AM; Tripathi B; DeSimone CV; Egbe A; Noseworthy PA; Kapa S; Mulpuru S; Gersh B; Mohamad A; Friedman P; Holmes D; Deshmukh AJ
Europace; 2021 Feb; 23(2):247-253. PubMed ID: 32929501
[TBL] [Abstract][Full Text] [Related]
7. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials.
Friedman DJ; Du C; Wang Y; Agarwal V; Varosy PD; Masoudi FA; Holmes DR; Reddy VY; Price MJ; Curtis JP; Freeman JV
JACC Cardiovasc Interv; 2022 May; 15(9):950-961. PubMed ID: 35512918
[TBL] [Abstract][Full Text] [Related]
8. Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device.
Cruz-González I; Korsholm K; Trejo-Velasco B; Thambo JB; Mazzone P; Rioufol G; Grygier M; Möbius-Winkler S; Betts T; Meincke F; Sandri M; Schmidt B; Schmitz T; Nielsen-Kudsk JE
JACC Cardiovasc Interv; 2020 Dec; 13(23):2732-2741. PubMed ID: 33189641
[TBL] [Abstract][Full Text] [Related]
9. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis.
Coylewright M; Holmes DR; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Yeh RW; Piccini JP; Price MJ; Allocco DJ; Nair DG
JACC Cardiovasc Interv; 2023 Nov; 16(22):2708-2718. PubMed ID: 37943200
[TBL] [Abstract][Full Text] [Related]
10. Intracardiac vs Transesophageal Echocardiography for Left Atrial Appendage Occlusion With Watchman FLX in the U.S.
Ferro EG; Alkhouli M; Nair DG; Kapadia SR; Hsu JC; Gibson DN; Freeman JV; Price MJ; Roy K; Allocco DJ; Yeh RW; Piccini JP
JACC Clin Electrophysiol; 2023 Dec; 9(12):2587-2599. PubMed ID: 37831030
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Safety and Effectiveness of LAAO: Insights From the Amulet IDE Trial.
Alkhouli M; Russo AM; Thaler D; Windecker S; Anderson JA; Gage R; Lakkireddy D
JACC Cardiovasc Interv; 2022 Nov; 15(21):2143-2155. PubMed ID: 36357018
[TBL] [Abstract][Full Text] [Related]
12. Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report From the NCDR LAAO Registry.
Price MJ; Valderrábano M; Zimmerman S; Friedman DJ; Kar S; Curtis JP; Masoudi FA; Freeman JV
Circ Cardiovasc Interv; 2022 May; 15(5):e011718. PubMed ID: 35369701
[TBL] [Abstract][Full Text] [Related]
13. Association of Hospital Procedural Volume With Outcomes of Percutaneous Left Atrial Appendage Occlusion.
Nazir S; Ahuja KR; Kolte D; Isogai T; Michihata N; Saad AM; Ramanathan PK; Krishnaswamy A; Wazni OM; Saliba WI; Gupta R; Kapadia SR
JACC Cardiovasc Interv; 2021 Mar; 14(5):554-561. PubMed ID: 33663783
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
[TBL] [Abstract][Full Text] [Related]
15. Device-Sizing and Associated Complications With Left Atrial Appendage Occlusion: Findings From the NCDR LAAO Registry.
Sandhu A; Varosy PD; Du C; Aleong RG; Tumolo AZ; West JJ; Tzou WS; Curtis JP; Freeman JV; Friedman DJ; Hess PL
Circ Cardiovasc Interv; 2022 Dec; 15(12):e012183. PubMed ID: 36472194
[TBL] [Abstract][Full Text] [Related]
16. Real-world experience with the new Watchman FLX device: Data from two high-volume Sicilian centers. The FLX-iEST registry.
Vizzari G; Grasso C; Sardone A; Mazzone P; Laterra G; Frazzetto M; Sacchetta G; Micari A; Tamburino C; Contarini M
Catheter Cardiovasc Interv; 2022 Jul; 100(1):154-160. PubMed ID: 35592941
[TBL] [Abstract][Full Text] [Related]
17. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Qiao J; Zhang B; Wang J; Pan L; Cheng T; Wang Y; Xiong E
Cardiology; 2022; 147(3):290-297. PubMed ID: 35468598
[TBL] [Abstract][Full Text] [Related]
18. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis.
Zhu MZ; Song H; Song GM; Bai X
Pacing Clin Electrophysiol; 2022 Oct; 45(10):1237-1247. PubMed ID: 35933600
[TBL] [Abstract][Full Text] [Related]
20. Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion.
Friedman DJ; Du C; Zimmerman S; Tan Z; Lin Z; Vemulapalli S; Kosinski AS; Piccini JP; Pereira L; Minges KE; Faridi KF; Masoudi FA; Curtis JP; Freeman JV
Circ Cardiovasc Interv; 2024 Jun; 17(6):e013466. PubMed ID: 38889251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
